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Spinal cord injury is a serious disabling condition. Transplantation of
olfactory ensheathing cells (OECs) is one of the most promising
treatments for spinal cord injury (SCI). Thirty‐nine patients with chronic
SCI received OEC transplantation and completed long‐term follow‐up,
with a minimum follow‐up of 7 years. We assessed sensorimotor
function with the American Spinal Injury Association (ASIA)
Impairment Scale (AIS) and autonomic nervous function by the
International Standards to document remaining Autonomic Function
after Spinal Cord Injury (ISAFSCI), and sympathetic skin responses
(SSR). The scores of each group were significantly higher after OECs
transplantation than before treatment. SSR latencies were shorter and
response amplitudes increased after treatment. Long‐term follow‐up
showed further improvement only in motor function and autonomic
function compared with 3 months postoperatively. No complications
occurred in any patient during long‐term follow‐up. The results indicate
that the transplantation of OECs in spinal cord restored function without
serious side effects.

© The authors 2021. This article
is published with open access at
http://jnr.tsinghuajournals.com
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Introduction

Spinal cord injury (SCI) is a common cause of
disability. Hundreds of thousands of patients
have chronic SCI in the United States and their
numbers are growing at more than 10,000 a year
[1]. SCI damages and kills cells in the spinal
cord, particularly neurons, oligodendrocytes,
astrocytes and precursor cells; regeneration of

these cells is very limited after injury. Thus,
nerve repair and neurological recovery after SCI
are unsolved problems for scientists and
clinicians. The main treatment of acute SCI is
surgical decompression to reduce secondary
injury. Therapeutic approaches for chronic SCI
primarily emphasize medicine and rehabilita‐
tion given primarily to relieve symptoms and
maximize residual function of SCI. Aside from
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drugs that manage symptoms caused by SCI,
currently no drugs or biologic therapies
approved by the United States Food and Drug
Administration (FDA) improve functional
recovery after SCI [2]. However, many
physicians and scientists have continued to test
neurorestorative therapies for SCI [3, 4] and
several have identified cell transplantation as a
potential treatment for SCI [3–8], especially
olfactory ensheathing cell (OEC) transplants as a
promising therapeutic approach [7, 8].
Accumulating clinical evidence indicate that
OECs interact with glial scars, stimulate
angiogenesis, axon outgrowth and remyelina‐
tion, improving functional outcomes in animal
SCI [3]. Similar long‐term clinical effects of the
OECs transplants for SCI have been confirmed
[6, 7]. OECs are thought to be one of the most
promising cells in the treatment of spinal cord
injury. Our previous studies also proved that
OEC transplantation can improve neural
function in patients with advanced SCI [8].
Nevertheless, its long‐term effectiveness and
safety need further research, in particularly, the
long‐term follow‐up of autonomic nervous
function with special cell transplantation is
rarely covered. In the present study, 39 chronic
SCI patients were treated with implantation of
OECs, and the clinical efficacy and safety of
OEC transplantation were studied by evaluating
their functional recovery in follow‐up.

2
2.1

Methods
Patients

This study enrolled 39 chronic spinal cord injury
patients (Table 1) and transplanted fetal OECs
from 2006 to 2007. The 38 males and 1 female
participant were an average age of 36.23 ± 8.47
years at the time of treatment. The mean
post‐injury period is 35.41 ± 41.8 months. Thirteen
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Table 1
patients.

Demographic and clinical characteristics of the

Characteristics
Sex

Type of injury

Level of injury

ASIA category

Type of catheter
on admission

Type of catheter
at follow up

Description

n

Percentage

Male

38

97.44%

Female

1

2.56%

Complete

16

41.03%

Incomplete

23

58.97%

Cervical

13

33.33%

Thoracic

23

58.97%

Lumbar

3

7.69%

A

14

35.90%

B

17

43.59%

C

3

7.69%

D

5

12.82%

IFC

5

12.82%

SPC

1

2.56%

CIC

33

84.62%

Without catheter
IFC

0
0

0
0

SPC

1

2.56%

CIC

33

84.62%

Without catheter

5

12.82%

cases had cervical SCI, 23 cases had thoracic SCI,
and 3 cases had lumbar segment.
All the patients were chosen if they fulfilled
the following inclusion criteria: (1) medical
records were complete; (2) the spinal cord injury
was at least half a year before treatment, (3) the
patient consented to the OEC transplantation.
All the patients received neurofunctional
evaluation of SCI using the America Spinal
Injury Association (ASIA) Impairment Scale
(AIS), assessment of autonomic nervous
function by using the International Standards to
document remaining Autonomic Function after
Spinal Cord Injury (ISAFSCI) and sympathetic
skin response (SSR).
All eligible patients and/or families were fully
informed about the study protocol and provided
written informed consents before participating
in the study. The Ethics Committee of Taian City
Central Hospital approved the study.
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2.2

Cell culture

The OEC were obtained for transplantation from
olfactory bulbs of fetuses aborted at 4 months.
After dissection and digestion with 0.25%
trypsin/0.53 mM ethylenediaminetetraacetic
acid (EDTA; Invitrogen, Carlsbad, CA, USA) for
10 min at 37 °C, the cells were suspended in
phosphate‐buffered saline (PBS) and cultured in
Dulbecco’s Modified Eagle’s Medium/F12
supplement (DMEM/F12; Gibco, Beijing, China)
with 10% fetal bovine serum (FBS; Gibco, Beijing,
China) for 3–4 days. The culture medium was
changed every 2–3 days and the cultures were
kept in a standard humidified air incubator
containing 5% CO2 and maintained at 37 °C.
When the cultures research 90% confluency, the
cells were passaged to attain the required
number of cells for the transplantation and
tested for phenotype and sterility, dissociated
with accutase (Invitrogen, San Diego, CA, USA),
suspended in saline at 100,000 cells/μL in saline,
and tested for viability using Trypan blue
exclusion to ensure that the cells were 95%
viable at time of transplantation [9].
2.3

Cell transplantation

Under general anesthesia, the spinal cord injury
site was exposed with a posterior midline
incision and incision of the meninx fibrosa. A
10 μL syringe (Hamilton, Reno, NV, USA) was
inserted into the spinal cord and the cell
suspension (10 μL) was slowly injected into two
sites along the midline to a depth of 2 mm, and
4 mm from the cranial and caudal sides of the
lesion epicenter, at a rate of 1.0 μL/min. After the
injections, the meninx fibrosa was tightly
sutured with absorbable sutures. Routine
hemostasis and antisepsis were carried out after
the operation. Drainage tubes (Hemovac, Davol,
Cranston, RI, USA) were placed to prevent
accumulation of body fluids at the surgery site
for 2–3 day.

2.4

Evaluation of spinal function

The investigators evaluated the patients at one
day before surgery and reevaluated the patients
at 3 months and 7 years postoperatively.
Therapeutic effects were assessed by comparing
preoperative and postoperative scores. The
motor and sensory functions were scored with
AIS. The autonomic function was evaluated by
the ISAFSCI [10] and SSR. A self‐evaluation
scale of autonomic nerve function was used at
the beginning. After ISAFSCI was released in
2009, the patients entered the ISAFSCI data to
assess autonomic nerve function at the follow‐
up examinations.
SSR was carried out on all patients, supine
and relaxed on a bed in a quiet dimly lit room.
The patients were asked to stay awake and quiet.
Environmental and skin temperatures were
seperately kept above 24 °C and 31 °C. SSR
was recorded by the Keypoint‐4 Electromyography/
Evoked Potential System (Medtronic; Minneapolis,
Minnesota, USA) from both upper limbs and
lower limbs and evoked by electrical stimulation
(0.2‐ms duration, 1‐Hz frequency, 0.5‐mV/D
sensitivity). The recording electrodes were
placed on the plantar surface of each foot and
the palm of each hand, and the references were
placed on the dorsum of the feet and hands
respectively. The tibial nerve was stimulated
using a saddle electrode in the medial malleolus
and the median nerve was stimulated in the
midline of the wrist using the same electrode.
The stimulus intensity was initially 40 mA, and
then increased to 60 mA. All patients received
four stimuli until a stable waveform was
observed. The interval between stimuli at
random intervals of more than 1 min to avoid
habituation. The sympathetic skin response
latency and amplitude were recorded 1 day
before transplantation as well as 3 months and 7
years after transplantation.
Journal of Neurorestoratology
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Statistical analysis

We analyzed the data using the commercial
statistical software package SPSS 13.0 (SPSS,
Chicago, IL, USA). Response amplitudes were
measured and expressed in mean ± SD.
Differences before and after transplantation (1 day,
3 months and follow‐up) were compared with
one‐way repeated measure ANOVA. A p‐value
of less than 0.05 was considered significant.

3

treatment compared to 3 months. ISAFSCI
scored did not differ significantly statistically
between 3 months postoperation and follow‐up.
Lower urinary tract, bowel and sexual function
improved after transplantation compared with
preoperative with statistical significance in all
groups.
3.3 Differences in AIS and ISAFSCI scores of
complete and incomplete SCI
To illustrate the difference in the efficacy of OEC

Results

transplantation in patients with complete and
3.1

incomplete SCI, we compared the improvement

AIS scores of patients

According to AIS, significant improvement of
sensorimotor function was showed in
postoperative 3 months and follow‐up compared
with preoperation (Table 2). However, there was
no significant difference of sensory function
between 3 months after surgery and follow‐up.
Only motor scores differed significantly com‐
paring 3 months after surgery and 7 years after
operation compared with 3 months after surgery.

of AIS score and ISAFSCI score between the two
groups. As can be seen from Table 4, the
improvement of sensory and motor scores in
patients with incomplete SCI was superior to
that in patients with complete SCI at 3 months
postoperatively and follow‐up, but only the
difference

in

exercise

improvement

was

statistically significant. The improvement of
autonomic nervous function in patients with
complete SCI was better than that in patients

3.2

Scores of ISAFSCI

with incomplete SCI, and the difference was

According to ISAFSCI (Table 3), general
autonomic function improved at 7 years after
Table 2

statistically significant at 3 months after surgery
and at follow‐up.

Comparison of patients scores by AIS.
Preoperative 1 day

Postoperative 3 months

Follow‐up

P*

P**

P***

Motor

50.92 ± 16.35

54.85 ± 17.16

56.62 ± 17.67

0.00

0.00

0.00

Light Touch

63.08 ± 22.63

66.15 ± 22.59

66.03 ± 22.48

0.00

0.00

0.91

Pin Prick

62.92 ± 22.61

66.59 ± 22.90

66.21 ± 22.72

0.00

0.00

0.33

P*, preoperative versus postoperative 3 months; P**, preoperative versus follow‐up; P***, postoperative 3 months versus follow‐up. Data
are shown as mean ± SEM, one‐way repeated measure ANOVA.

Table 3

Comparison of patients scores by ISAFSCI.
Preoperative

Postoperative 3 months

Follow‐up

P*

P**

P***

GAF

6.46 ± 2.723

8.82 ± 1.554

9.05 ± 1.450

0.00

0.00

0.14

LUT, bowel and sexual

11.23 ± 3.280

12.49 ± 4.777

12.59 ± 4.864

0.00

0.00

0.01

GAF, general autonomic function; LUT, lower urinaty tract. P*, preoperative versus postoperative 3 months; P**, preoperative versus
follow‐up; P***, postoperative 3 months versus follow‐up. Date are shown as mean ± SEM, one‐way repeated measure ANOVA.
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Table 4

The differences in AIS and ISAFSCI scores of complete and incomplete SCI.
Motor
3‐pre

Light touch
7‐pre

3‐pre

Pin prick

7‐pre

3‐pre

GAF

7‐pre

3‐pre

LUT, bowel and sexual
7‐pre

3‐pre

7‐pre

Complete SCI 1.92 ± 0.49 1.92 ± 0.49 1.7 ± 0.44 1.62 ± 0.41 1.88 ± 0.48 1.45 ± 0.37 2.32 ± 0.6 2.57 ± 0.66 3.68 ± 0.95 3.94 ± 1.01
Incomplete SCI 2.1 ± 0.42 3.09 ± 0.63 2.05 ± 0.41 2.19 ± 0.44 1.99 ± 0.4
p‐value

3.4

0.02

0.00

0.72

0.97

1.97 ± 0.4 1.92 ± 0.39 2.01 ± 0.41 2.64 ± 0.53 3.07 ± 0.62

0.62

0.26

0.24

0.15

0.03

0.02

by SCI itself or improper nursing care. After

SSR Results

hospitalization, all patients were cured except

Among 15 cases with complete SCI, 4 cases

for neuropathic pain, and there was no

showed a sympathetic skin response before

significant aggravation of neuropathic pain after

transplantation, and 7 cases showed a response

surgery or during follow‐up.

post‐treatment 3 months. Among the 24 subjects

After surgery, 11 patients developed low fever,

with incomplete SCI, all the cases can record

which was considered to be absorption fever

SSR both before and after transplantation. There

caused by open surgery. After symptomatic

were significant differences between SCI and

treatment, the body temperature returned to

healthy person in terms of SSR, significant

normal within 3 days (without antibiotics).

prolonged SSR latencies and decreased amplitude.

Cerebrospinal fluid leakage occurred in 1 case,

After

skin

which was stopped 4–12 days after compression

increased,

bandaging. Fat liquefaction occurred in 2 cases,

while the latency period significantly decreased

and the wound healed after removing the

(Only the latency between preoperative and

liquefaction tissue and pressing bandaging.

3

None of the 39 patients was infected. At

transplantation,

response

amplitude

months

after

the

sympathetic

significantly

transplantation

was

not

statistically significantly different, p = 0.148).
3.5

discharge, all patients had recovered from
postoperative complications.

Complication monitoring

In all 39 subjects of chronic spinal cord injury,
At the time of admission, there were 2 patients

follow‐up MRI’s showed that no evidence of

with urinary tract infection, 4 patients with

tumor,

neuropathic pain, 4 patients with pressure ulcer,

additional damage of the neural structure and

and 2 patients with autonomic dysfunction. All

pathological changes, such as infection (abscess),

the complications of these patients were caused

were found (Fig. 1).

Table 5

hemorrhage,

cyst

formation.

No

Quantitative SSR parameters in SCI patients before and after treatment
Preoperative

Postoperative 3 months

Follow‐up

P*

P**

P***

Lat (ms)

2323.19 ± 1330.13

1604.64 ± 280.14

785.23 ± 432.52

0.15

0.01

0.00

Ampl (μV)

149.43 ± 64.54

288.94 ± 115.70

831.80 ± 189.70

0.01

0.00

0.00

P*, preoperative versus postoperative 3 months; P**, preoperative versus follow‐up; P***, postoperative 3 months versus follow‐up. Data
are shown as means ± SEM, paired samples t‐test.
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Complication in SCI patients before and after treatment.
Description

Complications on admission

Postoperative complications

Complications at discharge

Complications during follow‐up

A

n

Percentage

Fever

0

0

Infection

2

5.13%

Neuropathic pain

4

10.26%

Decubitus

4

10.26%

Autonomic dysfunction

2

5.13%

Fever

11

28.21%

Infection

0

0

Cerebral spinal fluid leaks

1

2.56%

Operative incision of healing

2

5.13%

Neuropathic pain

4

10.26%

Fever

0

0

Infection

0

0

Cerebral spinal fluid leaks

0

0

Operative incision of healing

0

0

Neuropathic pain

4

10.26%

Tumor

0

0

Cyst formation

0

0

Abscess

0

0.00%

Neuropathic pain

4

10.26%

B

Fig. 1 Example images of the follow‐up MRI. (A) MRI of a patient with T10 SCI 9 years postoperatively. (B) MRI of a patient with
L2 SCI 7 years postoperatively.
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4

Discussion

The results of this study showed that OECs
transplantation improved sensory and motor
function in patients with advanced spinal cord
injury at long‐term follow‐up. This is consistent
with the results reported in other literature [6, 7,
11–13]. Different from other studies, this study
focused on the changes in autonomic nervous
function and evaluated autonomic nervous
function by using scale and SSR.
4.1 The assessment of autonomic function after
SCI
Traumatic SCI interrupts connections between
higher centers and the spinal cord. Disruption
of descending autonomic pathways causes
abnormalities in multiple organ systems,
including cardiovascular function, respiratory
functions, bowel, bladder, sexual function,
sudomotor activity, and thermoregulation.
Particularly, impairment of micturition and
gastrointestinal function have major effects on
the quality of life of people with SCI.
Cardiovascular/renal dysfunction is the leading
cause of death following SCI [14].
Most studies of therapies of SCI have focused
on motor and sensory loss, and few inves‐
tigators has looked at recovery of autonomic
dysfunctions. The first internationally accepted
standards used to document impairments of
motor and sensory function after SCI were
published in 1992, the merging of 3 standards
used to assess neurological function after SCI,
specifically the International Spinal Cord Society
(ISCoS), the American Spinal Injury Association
(ASIA), and the National Acute Spinal Cord
Injury Study (NASCIS) standards, now
sometimes called International Standards for
Neurological Classification of Spinal Cord
Injury (ISNCSCI).

In 2009, ASIA and ISCoS developed the first
framework for the assessment and documenta‐
tion of specific autonomic function in individuals
following SCI and published the first version of
the ISAFSCI in spinal cord [15].
ISAFSCI documents four components of the
autonomic system, including general autonomic
function, bladder, bowel and sexual functions,
and a urodynamic evaluation. A second edition
of ISAFSCI was published in 2012, omitting the
urodynamic evaluation because of the complex
methodology and interpretation of the test.
However, both ASIA and ISCoS strongly
recommended urodynamic studies as a part of
their SCI autonomic assessment [10]. Presently,
only limited data are available on the use of
ISAFSCI in the community [16].
In this study, we used the first edition of
ISAFSCI that excluded the urodynamic
evaluations but followed the patients for at least
7 years. That is to say, this article is the longest
follow‐up study of ISAFSCI since it was first
published in 2012. The results of this study
demonstrated significant impairment and
recovery of autonomic nervous system, as well
as function improvement of ISAFSCI scores after
OEC transplantation (3 months and 7 years).
Although ISAFSCI is a reasonable tool for
evaluating autonomic dysfunction after SCI, it is
a relatively subjective and insensitive tool. For
that reason, we added SSR to help evaluate
autonomic nerve function after SCI.
SSR is an important non‐invasive clinical
assessment of sudomotor function, which
provides an electrophysiological evaluation of
sympathetic cholinergic pathways controlling
the sweat glands and is widely used in various
clinical populations, such as multiple sclerosis
[17] and Parkinson’s disease [18]. SSR was first
used to assess patients with SCI in 1992.
Hanson et al. [19] found that SSRs showed
Journal of Neurorestoratology
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similar latencies as normal subjects but were
more variable and the responses had a lesser
amplitudes and required stronger stimulus
intensities. Subjects with complete quadriplegia
at a high neurological level (C2–T3) lacked SSRs
in hands and feet. In complete paraplegia
(T4–T8), SSR could be elicited in the hand but
not the feet, whereas they could usually be
elicited at both sites for complete SCI subjects
with lesions below T8. When SSR’s were present,
SSR potentials in SCI usually showed abnormal
latencies and amplitudes depending on the
injury level [20]. Our results also agree with
these studies. According to the results
concerning of ISFASCI and SSR, SCI can
seriously affect the autonomic nerve function in
patients, similar to the motor and sensation
function. OEC transplantation can improve the
autonomic nervous function significantly.
4.2 Clinical effect of olfactory ensheathing cell
transplants
The study showed that scores of sensorimotor
and autonomic functions significantly improved
(p < 0.05) compared to pre‐treatment scores. This
result suggests clinical effects of OEC
transplants and these effects did not change
with time. Although motor and LUT, bowel and
sexual function significantly differed between
3‐month and 7 year follow‐up after trans‐
plantation, some OEC transplant effects may be
time‐bound and short‐term. OECs may have
neuroprotective effects, inhibit glial scar
formation, promote axon remyelination, and
axon regeneration or sprouting. OECs may also
produce or secrete biochemical or growth
factors which can activate quiescent axons to
improve outcome transiently. However, there is
no evidence that OECs directly promote
regeneration of neurons and so its effect on
neural restoration is limited.
Long‐term improvement of motor function
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may be related to activities of daily life after SCI.
Improvement of motor function may result from
daily activities, especially in improvement of the
sitting and body position changes. Daily life
activities may contribute to recovery [8]
regardless of rehabilitation intervention. For
example, regular bladder emptying occurs
regardless of method used (e.g. suprapubic
catheters, indwelling urethral catheterization, or
intermittent catheterization). Such activities
bladder function may improve help empty the
bladder and have significant training effect.
Compared with complete SCI, patients with
incomplete SCI had more significant motor
function recovery, which was consistent with
more complete spinal cord structure in patients
with incomplete SCI. The recovery of sensory
function was also better than that of complete
SCI, but there was no statistical difference in
this study, which may be related to that the
assessment of sensory function is subjective and
slight improvements may not be felt by patient.
This suggests that it is necessary to apply more
objective and accurate sensory nerve evaluation
method.
In contrast to motor and sensory recovery,
autonomic function was more pronounced in
patients with complete spinal cord injury. This
may be related to the higher level of autonomic
nervous function in patients with incomplete
SCI than in patients with complete SCI.
However, the results of SSR also indicated that
the increase of SSR extraction rate in patients
with complete SCI after surgery indicates that
the patient had a change “from nothing”, which
may be more easily perceived by patients.
The OEC transplants poses two potential risks
to the patients. First, surgical complications
include infection and secondary SCI [21]. Our
results indicate no obvious postoperative
infection or further neural damage based on
neurologic evaluations and SSR. Second, due
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to its stem cell properties, OEC can secrete
various neurotrophic and growth factors. While
we cannot completely rule out the possibility of
tumors and carcinogenicity of the transplanted
cells, the 7‐year follow‐up MRI examinations
revealed no tumor or biological growth had
been found at the injection site and its adjacent
area. Taken together, the lack of complication
over 7 years suggests that these cells are
relatively safe to transplant and may have
beneficial effects.

5

Conclusion

In this study, OECs transplantation improves
sensorimotor and autonomic nervous function
in patients, suggesting long‐term benefits over a
7 year period. We saw no significant long‐term
complications. Our findings strongly suggest
long term safety and efficacy.
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